Mr. Chris Shields reports

RELIQ HEALTH TECHNOLOGIES, INC. ANNOUNCES CEASE TRADE ORDER

The British Columbia Securities Commission (BCSC) has issued Reliq Health Technologies Inc. a failure-to-file cease trade order (FFCTO) pursuant to National Policy 11-207 -- Failure to File Cease Trade Orders and Revocations in Multiple Jurisdictions in respect of the securities of the company as a result of the company's delay to file its:

1. Annual audited financial statements for the year ended June 30, 2023;
2. Interim financial statements for the interim period ended Sept. 30, 2023;
3. Management's discussion and analysis for the year ended June 30, 2023, and for the interim period ended Sept. 30, 2023; and
4. Certification of annual and interim filings for the year ended June 30, 2023, and for the interim period ended Sept. 30, 2023.

All documents as required by National Instrument 51-102 -- Continuous Disclosure Obligations, and National Instrument 52-109 -- Certification of Disclosure in Issuers' Annual and Interim Filings (collectively, the documents).

The company previously announced that the BCSC had granted a further extension of its management cease trade order through Jan. 12, 2024. The delay from the company having the necessary resources to provide all information and support for the financial records required for the auditor to complete its audit and permit filing of the documents is continuing, and has continued longer than anticipated by the company.

The company is actively working with its auditor to address issues raised by its auditor in the audit process, to enable the audit to be completed so the company can file the documents as soon as possible, at which point the company will seek to have the FFCTO revoked and trading reinstated on the TSX Venture Exchange. The company has appointed a special committee with independent counsel and accounting advice, so that all issues raised are being properly and thoroughly addressed by the company. The company will provide an update via a news release in due course once it has further information on the issues raised by the auditor and the expected timing of filing the documents. The company also confirms, as of the date of this news release, that there is no other material information concerning the affairs of the company that has not been generally disclosed.

Reliq Health Technologies Inc.

Reliq Health Technologies is a rapidly growing global health care technology company that specializes in developing innovative virtual care solutions for the multibillion-dollar health care market. Reliq's powerful iUGO Care platform supports care co-ordination and community-based virtual health care. iUGO Care allows complex patients to receive high-quality care at home, improving health outcomes, enhancing quality of life for patients and families, and reducing the cost of care delivery. iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent costly hospital readmissions and emergency room visits.

We seek Safe Harbor.